Ocugen (OCGN) Retained Earnings (2014 - 2026)
Ocugen (OCGN) posted Retained Earnings of $429.5 million for Q1 2026, up 704078.69% on a QoQ basis from $61000.0 in Q4 2025, and up 220.81% year-over-year from $133.9 million in Q1 2025.
Ocugen (OCGN) Retained Earnings (2014 - 2026) Analysis & Trends
Ocugen's Retained Earnings history runs 13 years deep, the most recent figure standing at $429.5 million for Q1 2026.
- Quarterly Retained Earnings rose 220.81% year-over-year to $429.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $429.5 million (up 220.81% YoY) and the FY2025 annual result came in at $61000.0, up 27.08% from the prior year.
- Retained Earnings was $429.5 million for Q1 2026 at Ocugen, up from $61000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $429.5 million in Q1 2026 and bottomed at -$390.4 million in Q3 2025.
- A 5-year average of -$122.4 million and a median of -$200.7 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2025 — Retained Earnings plunged 1697491.3% — and 2026, when it soared 220.81%.
- Ocugen's Retained Earnings stood at -$223.1 million in 2022, then retreated by 28.27% to -$286.2 million in 2023, then jumped by 100.02% to $48000.0 in 2024, then climbed by 27.08% to $61000.0 in 2025, then surged by 704078.69% to $429.5 million in 2026.
- Business Quant data shows OCGN's Retained Earnings at $429.5 million in Q1 2026, $61000.0 in Q4 2025, and -$390.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 429.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 429.55 Mn |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | -390.40 Mn |
| Jun 30, 2025 | 370.47 Mn |
| Mar 31, 2025 | -355.57 Mn |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | -313.40 Mn |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | -286.17 Mn |
| Sep 30, 2023 | -275.20 Mn |
| Jun 30, 2023 | -263.48 Mn |
| Mar 31, 2023 | -240.42 Mn |
| Dec 31, 2022 | -223.09 Mn |
| Sep 30, 2022 | -200.70 Mn |
| Jun 30, 2022 | -176.78 Mn |
| Mar 31, 2022 | -155.30 Mn |
| Dec 31, 2021 | 225.54 Mn |
| Sep 30, 2021 | 222.25 Mn |
| Jun 30, 2021 | 220.80 Mn |